FilingReader Intelligence
Southern Shuanglin Bio-Pharmacy: All resolutions passed at AGM
May 22, 2025 at 05:08 AM UTC•By FilingReader AI
Southern Shuanglin Bio-Pharmacy announced the results of its 2024 Annual General Meeting, confirming that all proposed resolutions were approved by shareholders. The meeting, held on May 21, 2025, combined on-site and online voting. Key resolutions passed include the 2024 Board and Supervisory Committee work reports, the 2024 annual report and financial statements, and the 2024 profit distribution plan.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Southern Shuanglin Bio-Pharmacy publishes news
Free account required • Unsubscribe anytime